Healthcare providers are making cybersecurity progress, but serious vulnerabilities remain — especially when it comes to AI ...

A bill introduced by Rep. Earl L. "Buddy" Carter would ban PBMs’ use of spread pricing in Medicaid, among other reforms.

Sarepta’s Elevidys will remain on the market with a black box warning. But this gene therapy for Duchenne muscular dystrophy still faces commercial headwinds and analysts say the company has ...

Most patients are open to the use of AI in healthcare — as long as it enhances, rather than replaces, human interaction, according to new research. It also showed that patients want transparency ...

A new survey from Mercer found that 51% of large employers said they are likely or very likely to make health benefit changes that would shift more costs to employees.

Hengrui’s peptide drug, HRS9531, is engineered to bind to and activate the GLP-1 and GIP receptors — the same two targets hit by blockbuster Eli Lilly’s chronic weight management drug ...